Top

Journal of the International AIDS Society

Published in:

Open Access 01-12-2010 | Poster presentation

Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data

Authors: E DeJesus, A Mills, L Bhatti, C Conner, S Storfer

Published in: Journal of the International AIDS Society | Special Issue 4/2010

Excerpt

Until recently, few prospective data existed to indicate safety/efficacy of NVP with entry CD4 count restricted to <250 (women) or <400 (men) cells/mm³. Two phase IV trials, ARTEN and NEWART, compared virologic safety/efficacy of NVP vs ATV/r on a background of TDF/FTC in HIV+ patients within these CD4 ranges. NEWART (US) was designed to be confirmatory of ARTEN and to supplement ARTEN data [1]. …

Soriano V, Köppe S, Migrone H, et al: International AIDS Society - 5th Conference on HIV Pathogenesis. Treatment & Prevention. 2009

Title: Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data
Authors: E DeJesus
A Mills
L Bhatti
C Conner
S Storfer
Publication date: 01-12-2010
Publisher: BioMed Central
Published in: Journal of the International AIDS Society / Issue Special Issue 4/2010
Electronic ISSN: 1758-2652
DOI: https://doi.org/10.1186/1758-2652-13-S4-P4

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 4/2010

What drives a normal relation between T-CD4 and T-CD8?

0231. Growing old with HIV — dealing with co-morbidities

T-CD4+ cell count at the date of the HIV diagnosis

Tenofovir use is associated with low vitamin D levels in a Spanish HIV cohort

O131. Treatment as prevention within the framework of current guidelines

British HIV and ageing study. HIV and ageing: older people with HIV, who are they?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page